VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in Headlands Technologies LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Headlands Technologies LLC reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.93% (2025 Q3)
Avg. % of fund
0.48%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 29,864 +22,507 +305.9% 0.93% $11.7M $391.64
2024 Q3 ADDED 7,357 +2,986 +68.3% 0.39% $3.4M $465.08
2024 Q2 ADDED 4,371 +1,956 +81.0% 0.22% $2.0M $468.72
2024 Q1 REDUCED 2,415 -2,294 -48.7% 0.24% $1.0M $418.01
2023 Q4 ADDED 4,709 +685 +17.0% 0.57% $1.9M $406.89
2023 Q3 ADDED 4,024 +2,544 +171.9% 0.69% $1.4M $347.74
2022 Q4 INITIATED 1,480 — — 0.34% $427K —
% of Fund (quarterly)    VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%
← Back to Headlands Technologies LLC Holdings